[Ocular toxicity of ethambutol].
D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002207:Capreomycin / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D003118:Color Perception; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014792:Visual Acuity; D014794:Visual Fields
D000636:Aminosalicylic Acids; D002207:Capreomycin; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Toxicité oculaire de l'éthambutol.